Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC for HER, too

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Find latest Breast videos · 900+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC for HER, too

By 2024 SABCS Annual Meeting Insights Hub FEATURING Sara A. Hurvitz

368 views

February 14, 2025

Comments 0

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

2.6K views

Year in Review 2024: Top Metastatic Breast Cancer Trials

Oncology 2024 Year in Review

V. Kaklamani

1.9K views

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

2.8K views

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

1.5K views

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

1.3K views

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

1.2K views

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

5.4K views

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

1.2K views

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.6K views

SABCS 2024 Insights: PATINA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

696 views

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

1.5K views

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

620 views

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.5K views

SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx

2024 SABCS Annual Meeting Insights Hub

V. Kaklamani

509 views

SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy…

2024 SABCS Annual Meeting Insights Hub

E. Hamilton

397 views

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

2.0K views

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

521 views

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

Kirollos Hanna

2.4K views

SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk N…

2024 SABCS Annual Meeting Insights Hub

N. Chen

417 views

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

1.1K views

AUTOPLAY

Login

Login

Join VuMedi

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC for HER, too

Related Videos

Oncology Clinical Updates - Review and Renew

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

Year in Review 2024: Top Metastatic Breast Cancer Trials

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

SABCS 2024 Insights: PATINA - Monday Morning Practice

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx

SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy…

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk N…

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …